|
|
Article: Product briefs: FDA okays 1/3-size cochlear implant
- Article from:
- The BBI Newsletter
- Article date:
- August 1, 1998
CopyrightCOPYRIGHT 1998 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A cochlear implant/processor combination to improve the hearing of severe to profoundly deaf adults, and profoundly deaf children who are very young, has been approved for commercialization by the FDA. The Nucleus 24 Channel Cochlear Implant, produced by Cochlear Corp. (Denver, Colorado), is an implant/processor combination one-third the size of other implants, enabling implantation in children as young as 18 months. Cochlear characterized the device as the "first true advance in cochlear implant technology in more than a decade, and one that com-bines the most sophisticated technology with the sim-plest, most cosmetically discreet external device avail-able." The implant is ...